BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessPoseida Therapeutics Presents Stem Cell Memory CAR-T Therapy for Prostate Cancer at 2018 Keystone Symposia on Emerging Cellular TherapiesBy Nasdaq OMXFeb 14, 2018, 1:01 PM UTC
BusinessExosome Diagnostics Significantly Expands Access and Coverage for its EPI Prostate Cancer Test through Agreement with FedMedBy Nasdaq OMXFeb 1, 2018, 12:35 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
BusinessEDAP Announces CMS Approval of New Reimbursement Code for HIFU Ablation of the ProstateBy Nasdaq OMXMay 22, 2017, 1:12 PM UTC
